Laboratory Medicine ›› 2017, Vol. 32 ›› Issue (8): 730-732.DOI: 10.3969/j.issn.1673-8640.2017.08.016
• Orginal Article • Previous Articles Next Articles
Received:
2016-12-28
Online:
2017-08-30
Published:
2017-09-01
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2017.08.016
核型 | 例数 | 产前诊断指征 |
---|---|---|
21-三体综合征(47,XN,+21) | 7 | 高龄+胎儿十二指肠闭锁 高龄+胎儿先天性心脏病 胎儿颈项透明带增厚 胎儿颈项透明带增厚+左心室强光斑 产前筛查高风险+高龄+羊水多 产前筛查高风险 产前筛查高风险 |
18-三体综合征(47,XN,+18) | 3 | 产前筛查高风险+高龄 产前筛查高风险+胎儿多发畸形 产前筛查高风险+胎儿多发畸形 |
13-三体综合征(46,XX,+13) | 1 | 胎儿唇裂+足掌中凸+耳廓畸形 |
平衡易位[46,XX,t(4;11)] | 1 | 不良孕史 |
罗伯逊易位[45,XY,rob(13;14)] | 1 | 不良孕史 |
性染色体异常 | ||
47,XXX 45,X | 2 1 | 无创DNA提示X三体 胎儿全身水肿 |
其他结构异常 | ||
46,XY,add(3)(q29) | 1 | 不良孕史 |
46,XX,inv(9) | 1 | 不良孕史+高龄 |
46,XX.del(15)(q22-qter) | 1 | 不良孕史 |
核型 | 例数 | 产前诊断指征 |
---|---|---|
21-三体综合征(47,XN,+21) | 7 | 高龄+胎儿十二指肠闭锁 高龄+胎儿先天性心脏病 胎儿颈项透明带增厚 胎儿颈项透明带增厚+左心室强光斑 产前筛查高风险+高龄+羊水多 产前筛查高风险 产前筛查高风险 |
18-三体综合征(47,XN,+18) | 3 | 产前筛查高风险+高龄 产前筛查高风险+胎儿多发畸形 产前筛查高风险+胎儿多发畸形 |
13-三体综合征(46,XX,+13) | 1 | 胎儿唇裂+足掌中凸+耳廓畸形 |
平衡易位[46,XX,t(4;11)] | 1 | 不良孕史 |
罗伯逊易位[45,XY,rob(13;14)] | 1 | 不良孕史 |
性染色体异常 | ||
47,XXX 45,X | 2 1 | 无创DNA提示X三体 胎儿全身水肿 |
其他结构异常 | ||
46,XY,add(3)(q29) | 1 | 不良孕史 |
46,XX,inv(9) | 1 | 不良孕史+高龄 |
46,XX.del(15)(q22-qter) | 1 | 不良孕史 |
[1] | 司艳梅,杨树法,王昕,等. 荧光原位杂交技术与染色体核型分析在产前诊断中的应用[J]. 中国优生与遗传,2016,36(1):55-56. |
[2] | 吴菁,钟梅,卢建,等. 改进荧光原位杂交技术快速产前诊断常见染色体异常[J]. 中华医学遗传学杂志,2011,28(6):658-660. |
[3] | CAINE A,MALTBY A E,PARKIN C A.Prenatal detection of Down's syndrome by rapid aneuploidy testing for chromosomes 13,18,and 21 by FISH or PCR without a full karyotype:a cytogenetic risk assessment[J]. Lancet,2005,366(9480):123-128. |
[4] | JIA C W,WANG S Y,MA Y M,et al.Fluorescence in situ hybridization in uncultured amniocytes for detection of aneuploidy in 4 210 prenatal cases[J]. Chin Med J(Engl),2011,124(8):1164-1168. |
[5] | TOUTAIN J,EPINEY M,BEGORRE M.First-trimester prenatal diagnosis performed on pregnant women with fetal ultrasound abnormalities:the reliability of interphase fluorescence in situ hybridization(FISH)on mesenchymal core for the main aneuploidies[J]. Eur J Obstet Gynecol Reprod Biol,2010,149(2):143-146. |
[6] | KAGAN K O,CHITTY L S,CICERO S,et al.Ultrasound findings before amniocentesis in selecting the method of analysing the sample[J]. Prenat Diagn,2007,27(1):34-39. |
[7] | SHAFFER L G,COPPINGER J,MORTON S A,et al.The development of a rapid assay for prenatal testing of common aneuploidies and microdeletion syndromes[J]. Prenat Diagn,2011,31(8):778-787. |
[8] | CHEN C P,CHEN M,SU Y N,et al.Inv dup del(10q):identification by fluorescence in situ hybridization and array comparative genomic hybridization in a fetus with two concurrent chromosomal rearrangements[J]. Taiwan J Obstet Gynecol,2012,51(2):245-252. |
[1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
[2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
[3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
[4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
[5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
[6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
[7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
[8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
[9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
[10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
[11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
[12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
[13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
[14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
[15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||